Feature | May 15, 2012 | Dave Fornell

Recently Introduced Contrast Injectors

Medrad, Covidien release next generation systems

Recently Introduced  Contrast Injectors

The Bayer/Medrad Mark 7 Arterion angiographic injector is designed for better ergonomics, to be small, light-weigh and easy to use.

Two next-generation automated contrast injector systems were recently introduced in the United States. 

In March 2012, Covidien began its global launch of a new version of its Optivantage dual-head computed tomography (CT) contrast media delivery system that allows simultaneous injection. The vendor said simultaneous injection and use of prefilled syringes offer technicians flexibility. The prefilled syringes also help minimize the risk of contamination from filling empty syringes. The system offers Covidien’s Optibolus software to deliver contrast media at a decelerating exponential rate compared to the standard constant rate of uniphasic injections.

At RSNA 2011, Medrad (now Bayer) introduced the Mark 7 Arterion angiographic injection system. The system is much smaller, lighter-weight, more ergonomic and easier to maneuver than previous Medrad injectors. It also is easier to operate than previous models, requiring less time to position and set up. It has a clearly visible and intuitive user interface to guide the user through proper set-up, and highlights the information needed to perform injections.

The Mark 7 Arterion has a unique front loading system to simplify set-up and makes for a cleaner tear down. The Mark 7 Arterion syringe provides a clear view of the contrast. 

Bracco Acquires Swiss Medical Care

In January, Bracco Imaging SpA acquired Swiss Medical Care (SMC), a Swiss contrast injector system vendor. The acquisition is a continuation of Bracco’s expansion into the injector market, after previously purchasing Acist and EZEM. The company said Swiss Medical will further strengthen its portfolio of solutions for radiology and diagnostic imaging. Swiss Medical said the merger will help expand sales of its CT Exprés computed tomography syringe-less contrast injector, which gained U.S. Food and Drug Administration approval in December 2006.

 Connecting Injector Data to EMRs

At RSNA 2011, Medrad released the Certegra Informatics Connect.RIS vendor-neutral informatics application to establish connectivity between Medrad’s Stellant contrast-injection systems and hospital information systems.  The application auto-populates contrast-injection records into reporting systems, eliminating the need to look for or dictate contrast-injection records.

Related Content

Guerbet presented its Contrast&Care injection management solution at ECR 2018

News | Contrast Media | November 13, 2019
November 13, 2019 – Guerbet, a global specialist in...
Windsong Radiology Group

Windsong Radiology Group

Sponsored Content | Case Study | Contrast Media Injectors | October 30, 2019
Windsong Radiology Group is a New York-based radiolo
Bayer Introduces Medrad Stellant Flex CT Injection System
Technology | Contrast Media Injectors | September 11, 2019
Bayer announced the introduction of the Medrad Stellant Flex computed tomography (CT) injection system. Stellant Flex...
Example of full-dose, 10 percent low-dose and algorithm-enhanced low-dose. Image courtesy of Enhao Gong, Ph.D.

Example of full-dose, 10 percent low-dose and algorithm-enhanced low-dose. Image courtesy of Enhao Gong, Ph.D.

Feature | Contrast Media Injectors | April 11, 2019 | By Jeff Zagoudis
One of the most controversial issues in radiology in recent years has been the use of...
GU12171120

GU12171120

Sponsored Content | Case Study | Contrast Media Injectors | April 02, 2019
The continuing search for advantages to improve workflow has radiology departments constantly searching for new solut
Guerbet Showcases Diagnostic and Interventional Imaging Solutions at RSNA 2018
News | Interventional Radiology | December 12, 2018
Guerbet LLC USA highlighted new and next-level product offerings and partnerships in contrast media, injectors,...
Guerbet Launches Multi-Use OptiVantage Contrast Media Injector in Europe
Technology | Contrast Media Injectors | December 05, 2018
Contrast agent company Guerbet recently announced that the OptiVantage multi-use contrast media injector is now CE...
OptiStar Elite injector
Feature | Contrast Media Injectors | March 07, 2018 | Grand View Research Inc.
The global contrast media injectors market is expected to reach $1.4 billion by 2025, growing at a compound annual...
TriHealth in Cincinnati

TriHealth in Cincinnati.

Sponsored Content | Case Study | Contrast Media Injectors | March 06, 2018
The continuing search for advantages to improve workflow has radiology departments constantly searching for new...